130 results
Page 2 of 7
6-K
EX-10.1
b1asx26ml oho
25 Aug 23
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
6:07am
6-K
EX-99.1
93bms7ir3 n9g6j
25 Aug 23
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
6:07am
6-K
EX-99.1
r0x0630w1y0c7f aozre
15 May 23
Celyad Oncology announces receipt of Nasdaq delisting notice
7:21pm
6-K
EX-99.1
xond5fshp j9
5 May 23
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
7:22am
6-K
EX-99.1
5kt67w szwz
5 May 23
Celyad Oncology Announces Intent to
7:21am
6-K
EX-99.1
e3hrwmz1
24 Apr 23
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
4:13pm
6-K
EX-99.1
m1s9z38e8a7u95nr i2
5 Apr 23
Celyad Oncology announces receipt of Nasdaq notice
7:45am
6-K
EX-99.1
q974uhz5ub 3pyvowey
21 Dec 22
Current report (foreign)
6:59am
6-K
EX-99.1
rvjehb2 c9qck1rc0
10 Nov 22
Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights
4:14pm
6-K
EX-99.1
v6q4xgymowbxc
12 Oct 22
Celyad Oncology Provides Strategic Update
4:06pm
6-K
EX-99.1
0i12ed
5 Aug 22
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
6:11am
6-K
EX-99.2
uhklc2jm noi31eajyox
5 Aug 22
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
6:11am
6-K
EX-99.2
jzxpq33emshf asshf
6 May 22
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
5:23pm
6-K
EX-99.1
p7jspfasvubgmea 8c
24 Mar 22
Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
5:45pm
CORRESP
9kyekkc
21 Jan 22
Correspondence with SEC
12:00am
6-K
EX-99.2
4x60c0sgtf
13 Dec 21
Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition
4:19pm
6-K
EX-10.2
ju4vzzs
3 Dec 21
Celyad Oncology Announces $32.5 Million Private Placement with Fortress Investment Group
9:19am
6-K
EX-10.1
rh2b6
3 Dec 21
Celyad Oncology Announces $32.5 Million Private Placement with Fortress Investment Group
9:19am